Skip to main content
OpenTrials

Clinical trial condition

Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation

Explore clinical trials studying Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation trial results

Completed

A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis

NCT01931839

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation, +6 more
Locations
  • Birmingham, Alabama, United States
  • Anchorage, Alaska, United States
  • Tucson, Arizona, United States
  • Little Rock, Arkansas, United States
View all 166 locations
View Trial Details

Related conditions